Deep Medicine Acquisition Corp. (NASDAQ:DMAQ – Get Rating) saw a large increase in short interest during the month of October. As of October 31st, there was short interest totalling 5,900 shares, an increase of 210.5% from the October 15th total of 1,900 shares. Based on an average trading volume of 22,800 shares, the short-interest ratio is currently 0.3 days. Currently, 0.1% of the shares of the stock are sold short.
Deep Medicine Acquisition Trading Up 0.1 %
DMAQ stock opened at $10.10 on Friday. Deep Medicine Acquisition has a 12 month low of $9.70 and a 12 month high of $10.99. The firm has a 50-day moving average of $10.07 and a two-hundred day moving average of $10.02.
Get
Deep Medicine Acquisition alerts:
Institutional Trading of Deep Medicine Acquisition
Several hedge funds have recently made changes to their positions in the company. Saba Capital Management L.P. grew its stake in shares of Deep Medicine Acquisition by 11.2% in the 1st quarter. Saba Capital Management L.P. now owns 1,009,157 shares of the company's stock valued at $10,041,000 after buying an additional 102,016 shares during the period. Wolverine Asset Management LLC grew its stake in shares of Deep Medicine Acquisition by 3.3% in the 2nd quarter. Wolverine Asset Management LLC now owns 354,543 shares of the company's stock valued at $3,534,000 after buying an additional 11,300 shares during the period. Hsbc Holdings PLC purchased a new stake in shares of Deep Medicine Acquisition in the 1st quarter valued at approximately $2,976,000. Commonwealth of Pennsylvania Public School Empls Retrmt SYS purchased a new stake in shares of Deep Medicine Acquisition in the 1st quarter valued at approximately $498,000. Finally, Millennium Management LLC boosted its position in shares of Deep Medicine Acquisition by 29.5% during the 2nd quarter. Millennium Management LLC now owns 42,719 shares of the company's stock worth $426,000 after purchasing an additional 9,719 shares during the period. Hedge funds and other institutional investors own 89.62% of the company's stock.
About Deep Medicine Acquisition
(Get Rating)
Deep Medicine Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It focuses on identifying businesses in the healthcare industry.
Further Reading
- Get a free copy of the StockNews.com research report on Deep Medicine Acquisition (DMAQ)
- Hanesbrands May be Signaling a Bad Week for Retail Stocks
- Vision Hydrogen, Now Vision Energy, Puts Hopes In Stock Split
- Coupang Stock And Why You Should Care
- This Is No Time To Buy D.R. Horton Stock
- Tightly Held Wendy's Is Undervalued
Receive News & Ratings for Deep Medicine Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Deep Medicine Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
